Literature DB >> 34508834

Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review.

Nathalie Demoulin1, Selda Aydin2, Valentine Gillion3, Johann Morelle3, Michel Jadoul3.   

Abstract

Hyperoxaluria results from either inherited disorders of glyoxylate metabolism leading to hepatic oxalate overproduction (primary hyperoxaluria), or increased intestinal oxalate absorption (secondary hyperoxaluria). Hyperoxaluria may lead to urinary supersaturation of calcium oxalate and crystal formation, causing urolithiasis and deposition of calcium oxalate crystals in the kidney parenchyma, a condition termed oxalate nephropathy. Considerable progress has been made in the understanding of pathophysiological mechanisms leading to hyperoxaluria and oxalate nephropathy, whose diagnosis is frequently delayed and prognosis too often poor. Fortunately, novel promising targeted therapeutic approaches are on the horizon in patients with primary hyperoxaluria. Patients with secondary hyperoxaluria frequently have long-standing hyperoxaluria-enabling conditions, a fact suggesting the role of triggers of acute kidney injury such as dehydration. Current standard of care in these patients includes management of the underlying cause, high fluid intake, and use of calcium supplements. Overall, prompt recognition of hyperoxaluria and associated oxalate nephropathy is crucial because optimal management may improve outcomes.
Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium oxalate crystals; chronic kidney disease (CKD); crystallopathies; fat malabsorption; kidney failure; lumasiran; nephrolithiasis; oxalate; oxalate nephropathy; oxalosis; primary hyperoxaluria; review; secondary hyperoxaluria; steatorrhea; urolithiasis

Mesh:

Substances:

Year:  2021        PMID: 34508834     DOI: 10.1053/j.ajkd.2021.07.018

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Analysis and Characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei: Two Probiotic Bacteria that Can Degrade Intestinal Oxalate in Hyperoxaluric Rats.

Authors:  Yogita Mehra; Nachiappa Ganesh Rajesh; Pragasam Viswanathan
Journal:  Probiotics Antimicrob Proteins       Date:  2022-06-14       Impact factor: 5.265

Review 2.  Dietary Management of Chronic Kidney Disease and Secondary Hyperoxaluria in Patients with Short Bowel Syndrome and Type 3 Intestinal Failure.

Authors:  Maciej Adler; Ewen C Millar; Kevin A Deans; Massimo Torreggiani; Francesca Moroni
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

3.  Increased rates of supplement-associated oxalate nephropathy during COVID-19 pandemic.

Authors:  Peter Fong; Raghav Wusirika; Jose Rueda; Kalani L Raphael; Shehzad Rehman; Megan Stack; Angelo de Mattos; Renu Gupta; Kendall Michels; Firas G Khoury; Vanderlene Kung; Nicole K Andeen
Journal:  Kidney Int Rep       Date:  2022-09-11

Review 4.  Postbiotics and Kidney Disease.

Authors:  Chiara Favero; Laura Giordano; Silvia Maria Mihaila; Rosalinde Masereeuw; Alberto Ortiz; Maria Dolores Sanchez-Niño
Journal:  Toxins (Basel)       Date:  2022-09-06       Impact factor: 5.075

Review 5.  Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment.

Authors:  Ruth Belostotsky; Yaacov Frishberg
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.